FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18297411000001105: Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jan 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62688301000001115 Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62688401000001111 Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Is a Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free 28 tablet true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start